Myointimal Hyperplasia in a Patient with Neuromyelitis Optica (Devic’s Disease) after the Creation of an Arteriovenous Graft
Neuromyelitis optica, also known as Devic’s disease, is an autoimmune disorder that leads to the inflammation and demyelination of nerves. Devic’s disease primarily affects the optic nerve and spinal cord, but can lead to a significant loss of function throughout the body if not treated with steroid...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2017-11-01
|
Series: | Case Reports in Neurology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/480230 |
_version_ | 1818548671730417664 |
---|---|
author | Christina Rao Stephanie Fox Sapan S. Desai |
author_facet | Christina Rao Stephanie Fox Sapan S. Desai |
author_sort | Christina Rao |
collection | DOAJ |
description | Neuromyelitis optica, also known as Devic’s disease, is an autoimmune disorder that leads to the inflammation and demyelination of nerves. Devic’s disease primarily affects the optic nerve and spinal cord, but can lead to a significant loss of function throughout the body if not treated with steroid therapy or plasmapheresis. We recently saw a 62-year-old patient who received plasmapheresis for Devic’s disease through a PTFE arteriovenous graft in her left arm. Her graft clotted without warning, and percutaneous thrombolysis was not successful. A new vascular access was achieved with the use of an immediate-cannulation PTFE graft, and the patient received plasmapheresis immediately after her operation. However, the patient returned within 2 weeks with a thrombosed graft. Extensive myointimal fibrosis was noted within the brachial artery and axillary vein during a graft thrombectomy. Subsequent placement of a new arteriovenous fistula in her contralateral arm was eventually successful. Myointimal fibrosis may be a sequela of symptomatic antibody-positive Devic’s disease, and avoidance of synthetic materials may be indicated in this patient population to avoid exacerbation of an autoimmune response. |
first_indexed | 2024-12-12T08:23:19Z |
format | Article |
id | doaj.art-a70d82a9446b40289d0729b9dd4ae47c |
institution | Directory Open Access Journal |
issn | 1662-680X |
language | English |
last_indexed | 2024-12-12T08:23:19Z |
publishDate | 2017-11-01 |
publisher | Karger Publishers |
record_format | Article |
series | Case Reports in Neurology |
spelling | doaj.art-a70d82a9446b40289d0729b9dd4ae47c2022-12-22T00:31:21ZengKarger PublishersCase Reports in Neurology1662-680X2017-11-019325225510.1159/000480230480230Myointimal Hyperplasia in a Patient with Neuromyelitis Optica (Devic’s Disease) after the Creation of an Arteriovenous GraftChristina RaoStephanie FoxSapan S. DesaiNeuromyelitis optica, also known as Devic’s disease, is an autoimmune disorder that leads to the inflammation and demyelination of nerves. Devic’s disease primarily affects the optic nerve and spinal cord, but can lead to a significant loss of function throughout the body if not treated with steroid therapy or plasmapheresis. We recently saw a 62-year-old patient who received plasmapheresis for Devic’s disease through a PTFE arteriovenous graft in her left arm. Her graft clotted without warning, and percutaneous thrombolysis was not successful. A new vascular access was achieved with the use of an immediate-cannulation PTFE graft, and the patient received plasmapheresis immediately after her operation. However, the patient returned within 2 weeks with a thrombosed graft. Extensive myointimal fibrosis was noted within the brachial artery and axillary vein during a graft thrombectomy. Subsequent placement of a new arteriovenous fistula in her contralateral arm was eventually successful. Myointimal fibrosis may be a sequela of symptomatic antibody-positive Devic’s disease, and avoidance of synthetic materials may be indicated in this patient population to avoid exacerbation of an autoimmune response.https://www.karger.com/Article/FullText/480230Neuromyelitis opticaDevic’s diseaseMyointimal hyperplasiaAutoimmune diseasePlasmapheresis |
spellingShingle | Christina Rao Stephanie Fox Sapan S. Desai Myointimal Hyperplasia in a Patient with Neuromyelitis Optica (Devic’s Disease) after the Creation of an Arteriovenous Graft Case Reports in Neurology Neuromyelitis optica Devic’s disease Myointimal hyperplasia Autoimmune disease Plasmapheresis |
title | Myointimal Hyperplasia in a Patient with Neuromyelitis Optica (Devic’s Disease) after the Creation of an Arteriovenous Graft |
title_full | Myointimal Hyperplasia in a Patient with Neuromyelitis Optica (Devic’s Disease) after the Creation of an Arteriovenous Graft |
title_fullStr | Myointimal Hyperplasia in a Patient with Neuromyelitis Optica (Devic’s Disease) after the Creation of an Arteriovenous Graft |
title_full_unstemmed | Myointimal Hyperplasia in a Patient with Neuromyelitis Optica (Devic’s Disease) after the Creation of an Arteriovenous Graft |
title_short | Myointimal Hyperplasia in a Patient with Neuromyelitis Optica (Devic’s Disease) after the Creation of an Arteriovenous Graft |
title_sort | myointimal hyperplasia in a patient with neuromyelitis optica devic s disease after the creation of an arteriovenous graft |
topic | Neuromyelitis optica Devic’s disease Myointimal hyperplasia Autoimmune disease Plasmapheresis |
url | https://www.karger.com/Article/FullText/480230 |
work_keys_str_mv | AT christinarao myointimalhyperplasiainapatientwithneuromyelitisopticadevicsdiseaseafterthecreationofanarteriovenousgraft AT stephaniefox myointimalhyperplasiainapatientwithneuromyelitisopticadevicsdiseaseafterthecreationofanarteriovenousgraft AT sapansdesai myointimalhyperplasiainapatientwithneuromyelitisopticadevicsdiseaseafterthecreationofanarteriovenousgraft |